Pregnancy Clinical Trial
Official title:
Active Pregnancy Policy at Work. Greater Wellbeing and Lower Sickness Absence
In a cluster randomized design it will be investigated whether teaching local leaders how to implement active pregnancy policy results in less sickness absence among their pregnant employees. Further it will be investigated to what extent Active pregnancy policy is implemented at the departments and whether it results in higher sense of security and wellbeing among the pregnant employee. Finally the cost and benefits of the intervention will be analyzed.
Background: The majority of Danish women work during their reproductive years. Sickness
absence among pregnant women is frequent; more than one third of Danish women are on longterm
sick leave during pregnancy. Sick leave has been found associated with occupational exposures
and studies have shown that adjustment in exposure can reduce sick leave in pregnancy
indicating that there are potential preventive initiatives.
Design and outcomes: In a cluster randomized design it will be investigated whether teaching
local leaders how to implement active pregnancy policy results in less sickness absence among
their pregnant employees. It will further be investigated to what extent Active pregnancy
policy is implemented at the departments and whether it results in higher sense of security
and wellbeing among the pregnant employee. Finally the cost and benefits of the intervention
will be analyzed.
The study takes place at hospitals in the two regions on Zealand, Denmark (The Capital region
of Denmark and Region Zealand) and in the daycare sector in 2 municipalities located in The
Capital region of Denmark. The randomization will be at the level of departments, which will
be randomized to either intervention or control:
Intervention: The leaders are invited to a 3 hours seminar, where they will be taught in how
to implement active pregnancy policy at their department.
Control: as usual
All employees at the involved departments getting pregnant during the year of intervention
will be included in the study. They are to answer a questionnaire at 28th week of gestation
and their days of sick leave during pregnancy will be recorded. All leaders at the
departments are to answer two questionnaires, one before randomization and one after
intervention.
The intervention: At the 3 hours seminar the leaders will receive education containing: 1)
Updates on evidence on pregnancy and risk of occupational exposures, 2) information about the
rules in the area and the leader's responsibilities, 3) Answers and solutions to frequent
issues relating pregnant employees at work and 4) Introduction to Active Pregnancy policy.
The content of Active Pregnancy Policy: A congratulation letter to the pregnant employee
inviting her to a meeting. At the meeting her job task will be discussed and fears and
worries taken hand on. The aim is to adjust the job tasks to the employee and her special
need during her pregnancy. During the pregnancy the leader regularly evaluate with the
pregnant employee on how it goes and if there are needs for other or further adjustments. A
minimum of 3 planned meetings have to be held during the pregnancy. Further the leader shall
inform the other employees at the workplace about the arrangements made with the pregnant
employee.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03442582 -
Afluria Pregnancy Registry
|
||
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Enrolling by invitation |
NCT05415371 -
Persistent Poverty Counties Pregnant Women With Medicaid
|
N/A | |
Completed |
NCT04548102 -
Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman
|
N/A | |
Completed |
NCT03218956 -
Protein Requirement During Lactation
|
N/A | |
Completed |
NCT02191605 -
Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
|
N/A | |
Completed |
NCT02223637 -
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
|
||
Recruiting |
NCT06049953 -
Maternal And Infant Antipsychotic Study
|
||
Completed |
NCT02577536 -
PregSource: Crowdsourcing to Understand Pregnancy
|
||
Not yet recruiting |
NCT06336434 -
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT05412238 -
Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months
|
N/A | |
Not yet recruiting |
NCT04786587 -
Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
|
||
Not yet recruiting |
NCT05028387 -
Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
|
||
Completed |
NCT02783170 -
Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women
|
Phase 4 | |
Completed |
NCT02683005 -
Study of Hepatitis C Treatment During Pregnancy
|
Phase 1 | |
Recruiting |
NCT02507180 -
Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
|
||
Recruiting |
NCT02564250 -
Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women
|
N/A | |
Recruiting |
NCT02619188 -
Nutritional Markers in Normal and Hyperemesis Pregnancies
|
N/A | |
Completed |
NCT02528136 -
The Clinical Carbetocin Myocardium Trial
|
Phase 4 |